- Home
- PROK vs MAV Comparison
PROK vs MAV Comparison
Compare PROK & MAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- MAV
- Stock Information
- Founded
- PROK 2015
- MAV 2003
- Country
- PROK United States
- MAV United States
- Employees
- PROK 163
- MAV N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- MAV Finance Companies
- Sector
- PROK Health Care
- MAV Finance
- Exchange
- PROK Nasdaq
- MAV Nasdaq
- Market Cap
- PROK 212.4M
- MAV 202.6M
- IPO Year
- PROK N/A
- MAV N/A
- Fundamental
- Price
- PROK $1.66
- MAV $8.51
- Analyst Decision
- PROK Buy
- MAV
- Analyst Count
- PROK 5
- MAV 0
- Target Price
- PROK $4.50
- MAV N/A
- AVG Volume (30 Days)
- PROK 566.3K
- MAV 66.2K
- Earning Date
- PROK 11-12-2024
- MAV 01-01-0001
- Dividend Yield
- PROK N/A
- MAV 4.30%
- EPS Growth
- PROK N/A
- MAV N/A
- EPS
- PROK N/A
- MAV N/A
- Revenue
- PROK N/A
- MAV N/A
- Revenue This Year
- PROK N/A
- MAV N/A
- Revenue Next Year
- PROK N/A
- MAV N/A
- P/E Ratio
- PROK N/A
- MAV N/A
- Revenue Growth
- PROK N/A
- MAV N/A
- 52 Week Low
- PROK $1.18
- MAV $6.37
- 52 Week High
- PROK $4.44
- MAV $8.34
- Technical
- Relative Strength Index (RSI)
- PROK 46.29
- MAV 45.98
- Support Level
- PROK $1.50
- MAV $8.42
- Resistance Level
- PROK $1.90
- MAV $8.55
- Average True Range (ATR)
- PROK 0.15
- MAV 0.07
- MACD
- PROK -0.01
- MAV 0.01
- Stochastic Oscillator
- PROK 45.45
- MAV 60.00
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About MAV Pioneer Municipal High Income Advantage Fund Inc.
Pioneer Muni High Income Advantage Tr is a closed-end fund designed to pursue high current income exempt from regular federal income tax and as a secondary objective to seek capital appreciation. It predominantly invests in debt securities and other obligations issued by or on behalf of states, territories, and possessions of the United States and the District of Columbia and their political subdivisions, agencies, and instrumentalities, the interest on which is exempt from regular federal income tax.